Oncology

This infographic discusses the need for a tailored, patient-centered approach to addressing common conditions and risk factors to consider for long-term survivorship care of patients living with CLL.

This infographic is intended to provide Health Care Providers with an overview on Chronic Lymphocytic Leukemia (CLL).

This infographic is intended to provide Health Care Providers information on Best Practices for Managing BTK Inhibitors in Patients with a history of Cardiac Comorbidities.

This infographic is intended to provide Health Care Providers with an understanding of the importance of targeting Bruton's Tyrosine Kinase Pathway in Chronic Lymphocytic Leukemia (CLL).

This infographic explores treatment sequencing strategies for patients with CLL, highlighting the influence of multiple clinical, disease, and patient factors on treatment selection and sequencing.

This infographic includes when to treat CLL based on iwCLL criteria, identifying disease progression, and a CLL treatment algorithm.

This infographic highlights the role of non-covalent BTK inhibitors in addressing limitations of toxicity, acquired resistance, and providing treatment options for patients with MCL or CLL after failure on covalent BTK inhibitors and BCL-2 inhibitors.

This infographic presents a case study of a 78-year-old male patient diagnosed with Chronic Lymphocytic Leukemia (CLL), detailing his journey from initial diagnosis through third-line therapy, and offering expert insights throughout treatment sequencing.

This infographic emphasizes the importance of effective communication, self-advocacy, and education in positively impacting the quality of life and clinical outcomes for CLL patients.

The slide deck for HCPs will provide an understanding of mechanisms of Bruton's tyrosine kinase inhibition in CLL.